|
1
|
Howell A, Anderson AS, Clarke RB, Duffy
SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and
Harvie MN: Risk determination and prevention of breast cancer.
Breast Cancer Res. 16:4462014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bodai BI and Tuso P: Breast cancer
survivorship: a comprehensive review of long-term medical issues
and lifestyle recommendations. Perm J. 19:48–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyd NF, Martin LJ, Bronskill M, Yaffe MJ,
Duric N and Minkin S: Breast tissue composition and susceptibility
to breast cancer. J Natl Cancer Inst. 102:1224–1237. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y,
Davidson NE and Wan Y: Regulation of estrogen receptor signaling in
breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci.
71:15492014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Lindström LS, Foo JN, Rafiq S,
Schmidt MK, Pharoah PD, Michailidou K, Dennis J, Bolla MK, Wang Q,
et al: kConFab Investigators: 2q36.3 is associated with prognosis
for oestrogen receptor-negative breast cancer patients treated with
chemotherapy. Nat Commun. 5:40512014.PubMed/NCBI
|
|
6
|
Seneviratne S, Campbell I, Scott N,
Kuper-Hommel M, Round G and Lawrenson R: Ethnic differences in
timely adjuvant chemotherapy and radiation therapy for breast
cancer in New Zealand: a cohort study. BMC Cancer. 14:8392014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B, Senn HJ, Albain KS, Andre F,
Bergh J, et al: Panel members: Personalizing the treatment of women
with early breast cancer: highlights of the St Gallen International
Expert Consensus on the Primary Therapy of Early Breast Cancer
2013. Ann Oncol. 24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei J, Rudolph A, Moysich KB, Rafiq S,
Behrens S, Goode EL, Pharoah PP, Seibold P, Fasching PA, Andrulis
IL, et al: kConFab Investigators: Assessment of variation in
immunosuppressive pathway genes reveals TGFBR2 to be associated
with prognosis of estrogen receptor-negative breast cancer after
chemotherapy. Breast Cancer Res. 17:182015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Omoto Y and Iwase H: Clinical significance
of estrogen receptor β in breast and prostate cancer from
biological aspects. Cancer Sci. 106:337–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pastore MB, Jobe SO, Ramadoss J and
Magness RR: Estrogen receptor-α and estrogen receptor-β in the
uterine vascular endothelium during pregnancy: functional
implications for regulating uterine blood flow. Semin Reprod Med.
30:46–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mufudza C, Sorofa W and Chiyaka ET:
Assessing the effects of estrogen on the dynamics of breast cancer.
Comput Math Methods Med. 2012:4735722012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crooke PS, Justenhoven C, Brauch H,
Dawling S, Roodi N, Higginbotham KS, Plummer WD, Schuyler PA,
Sanders ME, Page DL, et al: GENICA Consortium: Estrogen metabolism
and exposure in a genotypic-phenotypic model for breast cancer risk
prediction. Cancer Epidemiol Biomarkers Prev. 20:1502–1515. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cardaci S and Ciriolo MR: TCA cycle
defects and cancer: when metabolism tunes redox state. Int J Cell
Biol. 2012:1618372012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Colditz GA: Relationship between estrogen
levels, use of hormone replacement therapy, and breast cancer. J
Natl Cancer Inst. 90:814–823. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yager JD and Davidson NE: Estrogen
carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leygue E, Dotzlaw H, Watson PH and Murphy
LC: Altered expression of estrogen receptor-α variant messenger
RNAs between adjacent normal breast and breast tumor tissues.
Breast Cancer Res. 2:64–72. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lanfranchi A and Brind J: Breast Cancer:
Risks and Prevention (4th). Breast Cancer Prevention Institute. New
York: 2007.
|
|
18
|
Zhou B, Moodie A, Blanchard AA, Leygue E
and Myal Y: Claudin 1 in breast cancer: new insights. J Clin Med.
4:1960–1976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zu H, Wang F, Ma Y and Xue Y:
Stage-stratified analysis of prognostic significance of tumor size
in patients with gastric cancer. PLoS One. 8:e545022013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang XR, Chang-Claude J, Goode EL, Couch
FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A,
et al: Associations of breast cancer risk factors with tumor
subtypes: a pooled analysis from the Breast Cancer Association
Consortium studies. J Natl Cancer Inst. 103:250–263. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Green LE, Dinh TA and Smith RA: An
estrogen model: the relationship between body mass index,
menopausal status, estrogen replacement therapy, and breast cancer
risk. Comput Math Methods Med. 2012:7923752012. View Article : Google Scholar : PubMed/NCBI
|
